RxDoctor Payments Data

Shannon Falbo, PA

Medical · Arvada, CONPI 1285998542

Payments from drug & device makers

$824in general payments, 2019–2025

Across 42 payments — averaging $19.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$297
  • GSK$105
  • Pfizer$86
  • Sanofi Pasteur Inc.$79
  • Johnson & Johnson$62
  • Lilly USA, LLC$56
  • plus $140 from 5 others

What the payments were for

  • Food & beverage$824100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie16$297
GSK6$105
Pfizer4$86
Sanofi Pasteur Inc.3$79
Johnson & Johnson2$62
Lilly USA, LLC3$56
AstraZeneca3$43
Exact Sciences2$40
Argenx US, Inc.1$26
Inogen, Inc.1$16
Bayer1$16

How this compares

$824 in reported general payments places this provider in the 60th percentile of 766 medical providers in Colorado.

See all medical providers in Colorado

Medicare billing

Part B allowed, 2024
$24,022
Medicare patients
98
Services billed
475

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide46$46,084
XareltoRivaroxaban16$20,712
TrulicityDulaglutide12$11,455
EliquisApixaban12$9,920
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,718
Stiolto RespimatTiotropium Br/Olodaterol Hcl12$3,113
Atorvastatin Calcium233$2,100
Levothyroxine Sodium208$1,937
Gabapentin62$1,924
Omeprazole87$1,452
Duloxetine Hcl38$1,012
Albuterol Sulfate HfaAlbuterol Sulfate30$954
Propranolol Hcl29$843
Bupropion XlBupropion Hcl28$776
Venlafaxine Hcl ErVenlafaxine Hcl29$724

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$62$20,71216 claims
Lilly USA, LLCTrulicity$56$11,45512 claims
PfizerEliquis$86$9,92012 claims
GSKTrelegy Ellipta$105$7,71812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 766 medical providers in Colorado.

Other medical in Arvada

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →